arrow
A

Aleksander Żurakowski

american heart of poland, topolowa 16, 32-500 chrzanów, poland
H指数:23
被引数:4,590

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Should the Approach to Pre-Procedural Cardiological Diagnostics in Patients with Peripheral Artery Disease Be Reconsidered? The Prevalence of Coronary Artery Disease in Asymptomatic Patients

周围动脉疾病患者术前心脏病学诊断方法是否应重新考虑?无症状患者的冠状动脉疾病患病率

2025-12-150
OAAI
Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial
2022-05-179
OAAI
Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI An Individual Patient-Level Meta-Analysis
2021-02-0132
OAAI
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6-and 24-month results of the DESSOLVE III OCT study
2021-02-013
OA
Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY
2021-02-0110
OA
Influence of Bleeding Risk on Outcomes of Radial and Femoral Access for Percutaneous Coronary Intervention: An Analysis From the GLOBAL LEADERS Trial
2021-01-017
OAAI
PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY
2020-11-0247
OAAI
Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial
2019-12-114
PREAI
Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial

采用超薄支架的西罗莫司洗脱冠状动脉支架治疗动脉粥样硬化病变的安全性和有效性 (TALENT): 一项前瞻性多中心随机对照试验

LANCET
IF88.5
2019-03-0177
PREAI
Clinical Randomized Trial Evaluating Novel, Microcrystalline, and Biocompatible Polymer Paclitaxel-Coated Balloon for the Treatment of Femoropopliteal Occlusive Disease The BIOPAC Trial
2018-12-019
PREAI
Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial

ST段抬高型心肌梗死药物洗脱支架置入后6个月与12个月双联抗血小板治疗 (dapt-stemi): 随机、多中心、非劣效性试验

2018-10-02128
OAAI
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
LANCET
IF88.5
2018-09-01604
PREAI